Mar 23, 9:23 PM PDT
Ryan Davis of Law360.com has an article (subscription required for full access) that begins, "While a Foley & Lardner LLP partner who filed a jargon-filled petition mostly written by a client escaped U.S. Supreme Court sanctions Monday, the justices nonetheless put attorneys on notice...
Mar 23, 9:47 AM PDT
Jacob Gershman has this post today at WSJ.com's "Law Blog." Aebra Coe of Law360.com has an article headlined " High Court Won't Discipline Foley Atty For Jumbled Petition " (subscription required for full access) that begins, "A Foley & Lardner LLP partner on Monday was freed of a...
Feb 24, 8:06 AM PST
Andrew Strickler of Law360.com has a report (subscription required for full access) that begins, "The Foley & Lardner LLP partner who drew a rare sanction threat from the U.S. Supreme Court for filing an impenetrable, jargon-packed petition he says was penned largely by his client may...
Former Foley & Lardner Tech Pro Returns From CooleyLaw360 (subscription)Foley & Lardner
LLP has announced that one of its former technology attorneys has returned from Cooley LLP, coming on as as a partner in Foley's Boston office and bringing extensive patent licensing experience. Matt Karlyn, who was a member of Cooley's ...
CDP Announces Climate Change Reporting Changes for 2015JD Supra (press release)
The following post is provided by our guest author, Karen Lutz from TRC Environmental Corporation. Karen can be reached at klutz trcsolutions.com. CDP, an international nonprofit organization that provides a global system for measuring, reporting and ...and more »
Patent Term Adjustment in the Post-RCE PeriodJD Supra (press release)
We know from Novartis v. Lee that a patent application does not earn “B delay” type Patent Term Adjustment (PTA) from the time an RCE is filed until a Notice of Allowance is issued, but an application still can earn PTA for “A delay” when the USPTO …and more »
Judge Finds Biosimilar Patent Procedures OptionalJD Supra (press release)
Judge Seeborg of the U.S. District Court for the Northern District of California issued an order in Amgen, Inc. v. Sandoz, Inc., ruling that the patent dispute resolution procedures of the Biologics Price Competition and Innovation Act (BPCIA) are …and more »